These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16003290)

  • 1. Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.
    Büchler M; Lebranchu Y; Bénéton M; Le Meur Y; Heng AE; Westeel PF; le Guellec C; Libert F; Hary L; Marquet P; Paintaud G
    Clin Pharmacol Ther; 2005 Jul; 78(1):34-42. PubMed ID: 16003290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
    Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
    Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients.
    Picard N; Prémaud A; Rousseau A; Le Meur Y; Marquet P
    Br J Clin Pharmacol; 2006 Oct; 62(4):477-84. PubMed ID: 16995869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.
    Pescovitz MD; Vincenti F; Hart M; Melton L; Whelchel J; Mulgaonkar S; McKay D; Leung M; Calleja E; Bouw MR
    Br J Clin Pharmacol; 2007 Dec; 64(6):758-71. PubMed ID: 17555465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC-MPS) co-administered with cyclosporine in the early-phase post-kidney transplantation.
    Stracke S; Shipkova M; Mayer J; Keller F; Zarghom A; Yang L; Henne-Bruns D; Wieland E
    Clin Transplant; 2012; 26(1):57-66. PubMed ID: 21299636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2].
    Royer B; Davani S; Bérard M; Kantelip JP; Muret P
    Ann Biol Clin (Paris); 2003; 61(3):251-8. PubMed ID: 12805001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
    Barraclough KA; Isbel NM; Franklin ME; Lee KJ; Taylor PJ; Campbell SB; Petchey WG; Staatz CE
    Ther Drug Monit; 2010 Dec; 32(6):723-33. PubMed ID: 21068647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
    El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
    Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.
    de Winter BC; van Gelder T; Mathot RA; Glander P; Tedesco-Silva H; Hilbrands L; Budde K; van Hest RM
    Ther Drug Monit; 2009 Oct; 31(5):585-91. PubMed ID: 19704401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
    Clin Pharmacol Ther; 2004 May; 75(5):434-47. PubMed ID: 15116056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of renal graft function on mycophenolic acid pharmacokinetics during the early period after kidney transplant.
    Mohammadpur AH; Nazemian F; Abtahi B; Naghibi M
    Exp Clin Transplant; 2008 Dec; 6(4):276-81. PubMed ID: 19338489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.
    Kovarik JM; Curtis JJ; Hricik DE; Pescovitz MD; Scantlebury V; Vasquez A
    Transplant Proc; 2006 Dec; 38(10):3456-8. PubMed ID: 17175302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.
    Prémaud A; Rousseau A; Picard N; Marquet P
    Ther Drug Monit; 2006 Apr; 28(2):274-7. PubMed ID: 16628144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy.
    Muller H; Solari S; Zuniga C; Guerra I; Troncoso J; Ovalle R; Morente J; Pedreros C
    Transplant Proc; 2007 Apr; 39(3):596-9. PubMed ID: 17445553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.
    Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C
    J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy.
    Oláh AV; Asztalos L; Ivády G; Varga E; Kovács AM; Kappelmayer J; Varga J
    Clin Chem Lab Med; 2011 Nov; 49(11):1849-53. PubMed ID: 21848499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
    Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A
    Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.